White Paper

Prescription Trends Across In-Network and Out-Of-Network Channels

Enlyte’s drug trends series analyzes pharmacy trends in work comp. Part 2 examines combined prospectively and retrospectively managed channels to provide a comprehensive view of pharmacy activity.
By:

White Paper Summary

While overall pharmacy trends align with evidence-based recommendations, the cost of prescriptions is increasing. This rise is primarily driven by high cost topicals, increased migraine medications, and rising average wholesale price for brand drugs. Part 2 of our series uncovers prescribing patterns across both in-network and out-of-network channels for a comprehensive view of all prescription activity.

Be sure to watch our drug trends page for more of this year’s series including reports, videos, podcasts, and more.

Register to download the full content

 

To learn more from Enlyte, please visit their website.

Enlyte is the parent brand of Mitchell | Genex | Coventry, a leader in cost-containment technology, independent medical exams (IME), provider and specialty networks, case management services, pharmacy benefit and disability management. The three businesses have recently aligned their joint industry expertise and advanced technology solutions into a combined organization of nearly 6,000 associates committed to simplifying and optimizing property, casualty and disability claims processes and services.